Nevakar Revenue and Competitors

Bridgewater, NJ USA

Location

$85M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Nevakar's estimated annual revenue is currently $4.1M per year.(i)
  • Nevakar received $30.0M in venture funding in December 2018.
  • Nevakar's estimated revenue per employee is $100,500
  • Nevakar's total funding is $85M.

Employee Data

  • Nevakar has 41 Employees.(i)
  • Nevakar grew their employee count by -33% last year.

Nevakar's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
Associate VP, Technical OperationsReveal Email/Phone
3
VP, R&DReveal Email/Phone
4
VP and Head OphthalmologyReveal Email/Phone
5
VP Human ResourcesReveal Email/Phone
6
SVP Program ManagementReveal Email/Phone
7
SVP Program Management and Regulatory AffairsReveal Email/Phone
8
Associate Director Regulatory AffairsReveal Email/Phone
9
Sr. Director, Quality & ComplianceReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Nevakar?

Repositioning Drugs for a Better Outcome. Nevakar is a specialty injectable pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$85M

Total Funding

41

Number of Employees

$4.1M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nevakar News

2022-04-20 - $ENDP Nevakar Injectables Receives U.S. FDA Approval Of ...

Endo International plc (ENDP) - Nevakar Injectables Receives U.S. FDA Approval of Ready-to-use Ephedrine Injection in a Prefilled Syringe.

2022-04-13 - Myopia Therapeutics Pipeline Analysis, 2022 – Insights into ...

... Clinical and Non-Clinical Studies, Emerging Therapies, and Treatment Algorithm | Companies- Eyenovia Bio, Sydnexis, Nevakar, and Others.

2022-03-22 - Nevakar Announces Closing of $12 Million Convertible Note ...

About Nevakar Inc. Nevakar Inc. is a fully integrated privately held, late-stage biopharmaceutical company with an extensive portfolio of...

2018-11-30 - Nevakar Completes $30M Financing

Nevakar Inc., a Bridgewater, New Jersey-based specialty pharmaceutical company developing multiple products in the ophthalmic and injectable areas, entered into a $20m senior secured term loan with Oxford Finance LLC. As part of the financing agreement, Nevakar may also access an additional $10 ...

2018-11-30 - Daily funding roundup - November 30th, 2018

Lentesplus.com raised $5M; MondoBrain raised $13.3M; Nevakar raised $20M; UrbanClap raised $50M Lentesplus.com: Lentesplus.com is a contact lens online retailer company. Lentesplus.com has raised $5 million in Series A funding, including from Palm Drive Capital, IGNIA and InQlab. Read more ROA ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.6M418%N/A
#2
$26.4M4137%$355M
#3
$4.9M41-7%N/A
#4
$7.4M44-10%N/A
#5
$8.8M44-14%N/A

Nevakar Funding

DateAmountRoundLead InvestorsReference
2016-08-01$55.0MUndisclosedArticle
2018-12-04$30.0MUndisclosedOxford Finance LLCArticle